(Replaced content with "{{SYSU-MEDICINE}} <html> </html>") |
|||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | |||
<html> | <html> | ||
Line 5: | Line 4: | ||
+ | <head> | ||
+ | <meta charset="UTF-8"> | ||
+ | <link rel="icon" type="image/png" href="https://static.igem.org/mediawiki/2016/2/2a/T--SYSU-MEDICINE--logo_32%2A32.png" sizes="16x16"> | ||
+ | <link rel="icon" type="image/png" href="https://static.igem.org/mediawiki/2016/2/2a/T--SYSU-MEDICINE--logo_32%2A32.png" sizes="32x32"> | ||
+ | <!-- Latest compiled and minified CSS --> | ||
+ | <!--<link href='//cdn.webfont.youziku.com/webfonts/nomal/92549/46882/57f3d7e1f629d81a5077d03f.css' rel='stylesheet' type='text/css' />--> | ||
+ | <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css" integrity="sha384-BVYiiSIFeK1dGmJRAkycuHAHRg32OmUcww7on3RYdg4Va+PmSTsz/K68vbdEjh4u" crossorigin="anonymous"> | ||
+ | <!--jQuery--> | ||
+ | <script src="https://code.jquery.com/jquery-3.1.1.min.js" integrity="sha256-hVVnYaiADRTO2PzUGmuLJr8BLUSjGIZsDYGmIJLv2b8=" crossorigin="anonymous"></script> | ||
+ | <!-- Latest compiled and minified JavaScript --> | ||
+ | <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js" integrity="sha384-Tc5IQib027qvyjSMfHjOMaLkfuWVxZxUPnCJA7l2mCWNIpG9mGCD8wGNIcPD7Txa" crossorigin="anonymous"></script> | ||
+ | <style> | ||
+ | /*font*/ | ||
+ | /*font*/ | ||
+ | @font-face{font-family:"HelveticaNeueW02-45Ligh";src:url('//www.eyeem.com/css/fonts/88fcd49a-13c7-4d0c-86b1-ad1e258bd75d.eot?#iefix');src:url('//www.eyeem.com/css/fonts/88fcd49a-13c7-4d0c-86b1-ad1e258bd75d.eot?#iefix') format("eot"),url('//www.eyeem.com/css/fonts/9a2e4855-380f-477f-950e-d98e8db54eac.woff') format("woff"),url('//www.eyeem.com/css/fonts/fa82d0ee-4fbd-4cc9-bf9f-226ad1fcbae2.ttf') format("truetype"),url('//www.eyeem.com/css/fonts/48d599a6-92b5-4d43-a4ac-8959f6971853.svg#48d599a6-92b5-4d43-a4ac-8959f6971853') format("svg")} | ||
+ | *{ | ||
+ | font-family:"HelveticaNeueW02-45Ligh","Arial",sans-serif; | ||
+ | letter-spacing: 0.4px; | ||
+ | line-height: 1.5em; | ||
+ | } | ||
+ | #HQ_page h1,#HQ_page h2,#HQ_page h3,#HQ_page h4,#HQ_page h5,#HQ_page p{ | ||
+ | font-family:"HelveticaNeueW02-45Ligh","Arial",sans-serif; | ||
+ | } | ||
+ | #HQ_page p{ | ||
+ | font-size: 20px; | ||
+ | } | ||
+ | #HQ_page td{ | ||
+ | padding:0; | ||
+ | border:0; | ||
+ | } | ||
+ | #HQ_page table { | ||
+ | border:0; | ||
+ | } | ||
+ | /*override wiki*/ | ||
+ | .menu_wrapper, #top_title, #sideMenu{display: none;} | ||
+ | #content { | ||
+ | width:100%; | ||
+ | padding:0; | ||
+ | margin: 16px auto; | ||
+ | } | ||
+ | #top_menu_under { | ||
+ | height: 0; | ||
+ | } | ||
+ | #top_menu_14 { | ||
+ | border-bottom: 0; | ||
+ | } | ||
+ | #globalWrapper { | ||
+ | font-size: 100%; | ||
+ | padding-bottom: 0; | ||
+ | } | ||
+ | #content { | ||
+ | margin-bottom: 0; | ||
+ | } | ||
+ | /*nav*/ | ||
+ | .navbar { | ||
+ | border-radius: 0; | ||
+ | height: 50px; | ||
+ | margin-bottom:0; | ||
+ | z-index: 25; | ||
+ | } | ||
+ | .navbar-inverse .navbar-brand { | ||
+ | color: #fff; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav>.active>a, .navbar-inverse .navbar-nav>.active>a:focus, .navbar-inverse .navbar-nav>.active>a:hover { | ||
+ | background-color: rgba(0,0,0,0); | ||
+ | color: #999; | ||
+ | font-weight:600; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav>li>a { | ||
+ | color: #fff; | ||
+ | font-weight:600; | ||
+ | } | ||
+ | .navbar-inverse .navbar-nav>li>a:hover { | ||
+ | color: #999; | ||
+ | font-weight:600; | ||
+ | } | ||
+ | .navbar-nav>li{ | ||
+ | top: -5px; | ||
+ | } | ||
+ | /*.mw-content-ltr ul, .mw-content-rtl .mw-content-ltr ul {*/ | ||
+ | /*margin: 0 0.1;*/ | ||
+ | /*}*/ | ||
+ | .dropdown-menu>li>a { | ||
+ | font-weight: 600; | ||
+ | } | ||
+ | .third-level-list { | ||
+ | top: -10px; | ||
+ | left: 150px; | ||
+ | } | ||
+ | .jumbotron{ | ||
+ | margin-bottom:0; | ||
+ | padding-top:10px; | ||
+ | padding-bottom:20px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron { | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 30px; | ||
+ | margin-bottom: 0; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container{ | ||
+ | width: 1170px; | ||
+ | margin: 20px auto; | ||
+ | font-size: 18px; | ||
+ | color: #888; | ||
+ | /*font-weight: bold;*/ | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .line{ | ||
+ | height: 2px; | ||
+ | background-color: #bbb; | ||
+ | width: 100%; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact { | ||
+ | margin-top: 20px; | ||
+ | margin-left: 10px; | ||
+ | height: 140px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .title{ | ||
+ | font-weight: bold; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul{ | ||
+ | list-style: none; | ||
+ | padding-left: 0; | ||
+ | margin-left: 0; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul.float-contact { | ||
+ | float:left; | ||
+ | width: 400px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul li { | ||
+ | margin-top: 5px; | ||
+ | margin-bottom: 5px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul li a img{ | ||
+ | width: 30px; | ||
+ | height: 30px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul li a { | ||
+ | color: #888; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact ul li a:hover, #jumbo-footer.jumbotron>.footer-container .contact ul li a:active, #jumbo-footer.jumbotron>.footer-container .contact ul li a:focus { | ||
+ | color: #888; | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .contact .float-contact-right { | ||
+ | float:right; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .copyright{ | ||
+ | margin-top: 5px; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .copyright .text { | ||
+ | font-size: 16px; | ||
+ | float: left; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .copyright .icon{ | ||
+ | float: right; | ||
+ | } | ||
+ | #jumbo-footer.jumbotron>.footer-container .copyright .icon img { | ||
+ | width: 25px; | ||
+ | height: 25px; | ||
+ | } | ||
+ | #wechatModal .modal-dialog{ | ||
+ | width: 332px; | ||
+ | margin-top: 100px; | ||
+ | z-index: 2000; | ||
+ | } | ||
+ | /*content*/ | ||
+ | .jumbotron .my-content{ | ||
+ | margin: 0 auto; | ||
+ | width: 960px; | ||
+ | } | ||
+ | .jumbotron .my-content h2 { | ||
+ | text-align: center; | ||
+ | font-weight: bolder; | ||
+ | font-size: 40px; | ||
+ | margin-bottom:30px; | ||
+ | } | ||
+ | .jumbotron .my-content p { | ||
+ | line-height: 1.5em; | ||
+ | font-size: 20px; | ||
+ | color: #333; | ||
+ | } | ||
+ | .jumbotron#content{ | ||
+ | background-color: #fff; | ||
+ | } | ||
+ | .jumbotron#content p a{ | ||
+ | color: #333; | ||
+ | font-weight: bold; | ||
+ | } | ||
+ | .jumbotron#content img{ | ||
+ | width: 90%; | ||
+ | margin: 10px auto; | ||
+ | display: block; | ||
+ | } | ||
+ | .jumbotron#content span.note{ | ||
+ | width: 80%; | ||
+ | font-size: 16px; | ||
+ | color: #999; | ||
+ | margin: 0 auto; | ||
+ | display: block; | ||
+ | } | ||
+ | |||
+ | |||
+ | |||
+ | </style> | ||
+ | <script type="text/javascript"> | ||
+ | $(document).ready(function() { | ||
+ | // wechat qr code | ||
+ | var canHide= true; | ||
+ | $('#wechatModal').on('show.bs.modal', function (e) { | ||
+ | // do something... | ||
+ | $("#wechatModal").after('<div class="modal-backdrop fade in"></div>'); | ||
+ | }); | ||
+ | $(".modal").click(function() { | ||
+ | // console.log("click"); | ||
+ | //$(this).remove(); | ||
+ | if (canHide) { | ||
+ | $(".modal-backdrop").remove(); | ||
+ | $('#wechatModal').modal('hide'); | ||
+ | } | ||
+ | }); | ||
+ | $(".modal-dialog").click(function() { | ||
+ | canHide = false; | ||
+ | }); | ||
+ | $(".modal").mousemove(function() { | ||
+ | canHide = true; | ||
+ | }); | ||
+ | $(".third-level-list").css("left", "120px"); | ||
+ | // third level menu on nav | ||
+ | $(".third-level-menu").mouseenter(function() { | ||
+ | console.log("mouse in"); | ||
+ | $(this).addClass("open"); | ||
+ | |||
+ | }); | ||
+ | $(".third-level-menu").mouseleave(function() { | ||
+ | console.log("mouse in"); | ||
+ | $(this).removeClass("open"); | ||
+ | }); | ||
+ | $(".dropdown").mouseenter(function() { | ||
+ | $(this).addClass("open"); | ||
+ | }); | ||
+ | $(".dropdown").mouseleave(function() { | ||
+ | $(this).removeClass("open"); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
+ | </head> | ||
+ | <body> | ||
+ | <nav class="navbar navbar-inverse"> | ||
+ | <div class="container-fluid"> | ||
+ | <!-- Brand and toggle get grouped for better mobile display --> | ||
+ | <div class="navbar-header"> | ||
+ | <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"> | ||
+ | <span class="sr-only">Toggle navigation</span> | ||
+ | <span class="icon-bar"></span> | ||
+ | <span class="icon-bar"></span> | ||
+ | <span class="icon-bar"></span> | ||
+ | </button> | ||
+ | <a class="navbar-brand" href="https://2016.igem.org/Team:SYSU-MEDICINE"> | ||
+ | <img style="height: 40px; width: 40px; margin-top: -10px " src="https://2016.igem.org/wiki/skins/Igem/images/IGEM_white_letters.png"> | ||
+ | </a> | ||
+ | <a class="navbar-brand" href="https://2016.igem.org/Team:SYSU-MEDICINE">SYSU-MEDICINE</a> | ||
+ | </div> | ||
+ | |||
+ | <!-- Collect the nav links, forms, and other content for toggling --> | ||
+ | <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"> | ||
+ | <ul class="nav navbar-nav navbar-right"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE">HOME</a></li> | ||
+ | <li class="dropdown"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">PROJECT<span class="caret"></span></a> | ||
+ | <ul class="dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Description">Description</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Results">Results</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Protocol">Protocol</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Notebook">Notebook</a></li> | ||
+ | <li class="dropdown third-level-menu"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">For Judgement <span class="glyphicon glyphicon-chevron-right"></span></a> | ||
+ | <ul class="third-level-list dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Proof">Proof of Concept</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Demonstrate">Demonstrate</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li class="dropdown active"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">HUMAN PRACTICES<span class="caret"></span></a> | ||
+ | <ul class="dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Our_Story">Our Story</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview">Interview</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Ethics">Ethics</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Legislation">Legislation</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Products">Products</a></li> | ||
+ | <li class="dropdown third-level-menu"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">For Judgement <span class="glyphicon glyphicon-chevron-right"></span></a> | ||
+ | <ul class="third-level-list dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/HP/Silver">Silver</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/HP/Gold">Gold</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Integrated_Practices">Integrated Practices</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement">Engagement</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Modeling">MODELING</a></li> | ||
+ | <li class="dropdown"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">TEAM<span class="caret"></span></a> | ||
+ | <ul class="dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Team">Team</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Attributions">Attributions</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Collaborations">Collaborations</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | |||
+ | <li class="dropdown"> | ||
+ | <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">PARTS<span class="caret"></span></a> | ||
+ | <ul class="dropdown-menu"> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Parts">Parts</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Basic_Part">Basic Parts</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Composite_Part">Composite Parts</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Part_Collection">Part Collection</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Safety">SAFETY</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:SYSU-MEDICINE/Judging">JUDGING</a></li> | ||
+ | </ul> | ||
+ | </div><!-- /.navbar-collapse --> | ||
+ | </div><!-- /.container-fluid --> | ||
+ | </nav> | ||
+ | <!--content--> | ||
+ | <div class="jumbotron"> | ||
+ | <div class="my-content" style="width:1070px;"> | ||
+ | <h1 align="center">Silver</h1> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="jumbotron" id="content"> | ||
+ | <div class="my-content"> | ||
+ | <h2>HP for Silver</h2> | ||
+ | |||
+ | <p> | ||
+ | <br/> | ||
+ | During the project, HP devoted to study and investigate different aspects closely related to our project including ethics, law and legislation, safety, product analysis, even summary of room for improvement by means of literature studying, interview, questionnaire, attending Cell Therapy Annual Meeting etc. HP also had dialogue with high school students, college students and ordinary citizens.<br/> | ||
+ | <br/> | ||
+ | </p> | ||
+ | <h2>Ethics</h2> | ||
+ | <p> | ||
+ | This is a project about treatment, which will be used on human beings in the future. The ethic issues of our project contain three parts. Firstly, after we carried out an interview with doctors and patients, we found out there were some ethic issues between researchers and patients. Secondly, we searched information of animal welfare and learnt how to construct animal models because we would test our product on mice model. At last, we had a discussion on primate experiments. <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Ethics"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | </p> | ||
+ | <h2>Law and Regulation</h2> | ||
+ | <p> | ||
+ | Law and legislation are the vital factors of our product – MSCs preparation. During the researches of clinical trials, we found that there was no MSCs drug in China although there exist about 10 MSCs drugs in the world. Law and Regulation is the breakthrough point. So laws of several different countries were analyzed to compare with that of China, aiming to find a proper way for development of MSCs therapy in China. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Legislation"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | To know how far our project would go, we asked the secretory of Stem Cell Clinical Research Experts Committee if Conditional Approval is possible in China. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#laws"><b><u><font color="#e57d22">More</b></u></font></a> <br/> | ||
+ | <br/> | ||
+ | </p> | ||
+ | <h2>Safety</h2> | ||
+ | <p> | ||
+ | <br/> | ||
+ | For general view, you can see our <a href="https://2016.igem.org/Team:SYSU-MEDICINE/Safety"><b><u><font color="#e57d22">safety page</b></u></font></a> to have an overview of our investigation and discussion on safety. Second, there were two aspects that HP did during the project. One was the investigation of lab safety awareness of college students. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#question2"><b><u><font color="#e57d22">More</b></u></font></a> <br/> | ||
+ | The other one was to make sure our product is safe for human, we had researched on Quality Control of MSCs. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#safe"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | |||
+ | </p> | ||
+ | <h2>Product analysis</h2> | ||
+ | <p> | ||
+ | At the very beginning, we thought it was so far away for our product to bring to the market that it seemed unnecessary to do product analysis. A turning point appeared when we got to know Academician Wu’s research on a kind of MSCs drug, which encouraged us a lot and then we made a detailed product analysis including product contrastive analysis, cost analysis and intellectual property. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Products"><b><u><font color="#e57d22">More</b></u></font></a> <br/> | ||
+ | Additionally, we interviewed the chairman of DAAN Gene Company to know the attitudes towards our product. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Interview#daan_gene"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | |||
+ | </p> | ||
+ | <h2>Education & Sustainability</h2> | ||
+ | <p> | ||
+ | <br/> | ||
+ | Most middle school students in China have rare chances to do biochemical experiments. All they can learn is only the theory. Students and teachers from a middle school were invited to attend an activity – “Have a Look at Your Genome”, which aimed at sharing some basic knowledge of synthetic biology and what we were doing with iGEM. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#havealook"><b><u><font color="#e57d22">More</b></u></font></a> <br/> | ||
+ | To benefit more high school students, we wrote a guidebook on the three experiments for high school teachers so that any high school can carry out these experiments for students. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#brochure"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | MSCs therapy is one of the hot research fields in resent years. However, it is little-known by the public. We held a lecture to help medical students to have a further understanding of MSCs and made a brochure introducing to the public. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Engagement#gps"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | |||
+ | </p> | ||
+ | <h2> | ||
+ | Room for improvement | ||
+ | </h2> | ||
+ | <p> | ||
+ | <br/> | ||
+ | During the whole process of this project, for further understanding our project and MSCs, we have done a lot of Human Practices work, though it remains a pity that we have not done a great job in some aspects. This summary contains what we think we could do better during the project. | ||
+ | <a target="_blank" href="https://2016.igem.org/Team:SYSU-MEDICINE/Our_Story#improvement"><b><u><font color="#e57d22">More</b></u></font></a><br/> | ||
+ | <br/> | ||
+ | <br/> | ||
+ | |||
+ | </p> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <!--footer--> | ||
+ | <div class="jumbotron" id="jumbo-footer"> | ||
+ | <div class="footer-container"> | ||
+ | <div class="title"> | ||
+ | Contact us | ||
+ | </div> | ||
+ | <div class="line"></div> | ||
+ | <div class="contact"> | ||
+ | <ul class="float-contact"> | ||
+ | <li> | ||
+ | <a href="http://weibo.com/u/5999650333"> | ||
+ | <img style="height: 32px; width: 32px" src="https://static.igem.org/mediawiki/2016/0/06/T--SYSU-MEDICINE--weibo.png"> | ||
+ | iGEMxSYSU-MEDICINE | ||
+ | </a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="https://www.facebook.com/IGEM-SYSU-Medicine"> | ||
+ | <img style="height: 27px; width: 27px; margin-left: 2px;margin-right:2px;" src="https://static.igem.org/mediawiki/2016/a/a1/T--SYSU-MEDICINE--facebook.png"> | ||
+ | IGEM SYSU-Medicine | ||
+ | </a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="#"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/4/43/T--SYSU-MEDICINE--email.png"> | ||
+ | SYSU_MEDICINE@163.com | ||
+ | </a> | ||
+ | </li> | ||
+ | </ul> | ||
+ | <ul class="float-contact"> | ||
+ | <li> | ||
+ | <a href="#" data-toggle="modal" data-target="#wechatModal"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/6/6e/T--SYSU-MEDICINE--wechat.png"> | ||
+ | SYSU-MEDICINE | ||
+ | </a> | ||
+ | </li> | ||
+ | <li> | ||
+ | <a href="https://twitter.com/IgemSysu"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/1/1c/T--SYSU-MEDICINE--twitter.png"> | ||
+ | iGEM SYSU-MEDICINE | ||
+ | </a> | ||
+ | </li> | ||
+ | |||
+ | </ul> | ||
+ | <div class="float-contact-right"> | ||
+ | <img style="width: 140px" src="https://static.igem.org/mediawiki/2016/5/5e/T--SYSU-MEDICINE--Igemlogo_banner.png"> | ||
+ | <img style="height: 100px" src="https://static.igem.org/mediawiki/2016/d/df/T--SYSU-MEDICINE--SYSU-MEDICINE.png"> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="line"></div> | ||
+ | <div class="copyright"> | ||
+ | <div class="text"> | ||
+ | © 2016 SYSU-MEDICINE. All Rights Reserved. | ||
+ | </div> | ||
+ | <div class="icon" > | ||
+ | <img src="https://static.igem.org/mediawiki/2016/f/f5/T--SYSU-MEDICINE--china_2x.png"> | ||
+ | <img src="https://static.igem.org/mediawiki/2016/a/a9/T--SYSU-MEDICINE--SYSU.png"> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | <!-- Wechat QRCode Modal --> | ||
+ | <div class="modal fade" id="wechatModal" tabindex="-1" role="dialog" aria-labelledby="myModalLabel" data-backdrop="false"> | ||
+ | <div class="modal-dialog" role="document"> | ||
+ | <div class="modal-content"> | ||
+ | |||
+ | <div class="modal-body"> | ||
+ | <img style="height: 300px;width: 300px;" src="https://static.igem.org/mediawiki/2016/0/07/T--SYSU-MEDICINE--wechat-qrcode.png"> | ||
+ | </div> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </body> | ||
</html> | </html> |
Latest revision as of 22:10, 19 October 2016
Silver
HP for Silver
During the project, HP devoted to study and investigate different aspects closely related to our project including ethics, law and legislation, safety, product analysis, even summary of room for improvement by means of literature studying, interview, questionnaire, attending Cell Therapy Annual Meeting etc. HP also had dialogue with high school students, college students and ordinary citizens.
Ethics
This is a project about treatment, which will be used on human beings in the future. The ethic issues of our project contain three parts. Firstly, after we carried out an interview with doctors and patients, we found out there were some ethic issues between researchers and patients. Secondly, we searched information of animal welfare and learnt how to construct animal models because we would test our product on mice model. At last, we had a discussion on primate experiments. More
Law and Regulation
Law and legislation are the vital factors of our product – MSCs preparation. During the researches of clinical trials, we found that there was no MSCs drug in China although there exist about 10 MSCs drugs in the world. Law and Regulation is the breakthrough point. So laws of several different countries were analyzed to compare with that of China, aiming to find a proper way for development of MSCs therapy in China.
More
To know how far our project would go, we asked the secretory of Stem Cell Clinical Research Experts Committee if Conditional Approval is possible in China.
More
Safety
For general view, you can see our safety page to have an overview of our investigation and discussion on safety. Second, there were two aspects that HP did during the project. One was the investigation of lab safety awareness of college students.
More
The other one was to make sure our product is safe for human, we had researched on Quality Control of MSCs.
More
Product analysis
At the very beginning, we thought it was so far away for our product to bring to the market that it seemed unnecessary to do product analysis. A turning point appeared when we got to know Academician Wu’s research on a kind of MSCs drug, which encouraged us a lot and then we made a detailed product analysis including product contrastive analysis, cost analysis and intellectual property.
More
Additionally, we interviewed the chairman of DAAN Gene Company to know the attitudes towards our product.
More
Education & Sustainability
Most middle school students in China have rare chances to do biochemical experiments. All they can learn is only the theory. Students and teachers from a middle school were invited to attend an activity – “Have a Look at Your Genome”, which aimed at sharing some basic knowledge of synthetic biology and what we were doing with iGEM.
More
To benefit more high school students, we wrote a guidebook on the three experiments for high school teachers so that any high school can carry out these experiments for students.
More
MSCs therapy is one of the hot research fields in resent years. However, it is little-known by the public. We held a lecture to help medical students to have a further understanding of MSCs and made a brochure introducing to the public.
More
Room for improvement
During the whole process of this project, for further understanding our project and MSCs, we have done a lot of Human Practices work, though it remains a pity that we have not done a great job in some aspects. This summary contains what we think we could do better during the project.
More